The results of this TMA showed the same regulation of secernin-1 as the previous immunohistochemical analysis: tumor-free tissues showed significantly higher secernin-1 expression than tumors (P < 0.001), but no difference was found between patients with and without relapse (Figures 5(a)–5(h)). This evidence concerns the gene SCRN1 and neoplasm.